Apimeds Pharmaceuticals US (APUS) vs Lexaria Bioscience (LEXX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 10, 2026.
Summary
Apimeds Pharmaceuticals US is the larger company by market cap ($7.6 million vs $7.0 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | APUS | LEXX |
|---|---|---|
| Share price | $5.02 | $3.32 |
| Market cap | $7.58M | $6.99M |
| 1-day change | -8.89% | -1.19% |
| YTD return | -69.39% | — |
| 1-year return | -73.01% | — |
| EPS (TTM) | $-36.03 | $-5.10 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $59.70 | $21.60 |
| 52-week low | $1.51 | $2.77 |
| Distance from 52-week high | -91.59% | -84.63% |
| Analyst consensus | — | none |
| Avg. price target upside | — | +2384.94% |
| Average volume | 3.67M | 63.29K |
| Shares outstanding | 1.51M | 2.11M |
| Employees | — | 7 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Apimeds Pharmaceuticals US
APUS stock →Apimeds Pharmaceuticals US, Inc. provides digital asset treasury solutions in bitcoin treasury infrastructure.
Health Care · Biotechnology: Pharmaceutical Preparations
About Lexaria Bioscience
LEXX stock →Lexaria Bioscience Corp. operates as a biotechnology company.
Health Care · Biotechnology: Pharmaceutical Preparations · 7 employees
APUS vs LEXX FAQ
Which is bigger, Apimeds Pharmaceuticals US or Lexaria Bioscience?
Apimeds Pharmaceuticals US (APUS) is larger, with a market capitalization of $7.58M compared with $6.99M for Lexaria Bioscience (LEXX).
Are Apimeds Pharmaceuticals US and Lexaria Bioscience in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.